Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 3/20 | 0.31 |
| ▸ | MAT2A | P31153 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.31 |
| ▸ | XDH | P47989 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19912570 | 0.95 | KIF11 (0.34) | KIF11NR3C1PGRNR3C2TSHR | |
| SCHEMBL19912577 | 0.95 | KIF11 (0.43) | KIF11NR3C1PGRNR3C2TSHR | |
| SCHEMBL19912571 | 0.95 | TSHR (0.34) | KIF11TSHRSMN1; SMN2ARMAT2A | |
| SCHEMBL19912407 | 0.94 | KIF11 (0.38) | KIF11NR3C1PGRNR3C2AR | |
| SCHEMBL19903532 | 0.94 | KIF11 (0.41) | KIF11TSHRSMN1; SMN2ARMAT2A | |
| SCHEMBL20617042 | 0.91 | KIF11 (0.39) | KIF11TSHRSMN1; SMN2ARMAT2A | |
| SCHEMBL19912357 | 0.91 | KIF11 (0.35) | KIF11NR3C1PGRNR3C2TSHR | |
| SCHEMBL19912412 | 0.89 | KIF11 (0.34) | KIF11NR3C1PGRNR3C2TSHR | |
| SCHEMBL19912410 | 0.89 | KIF11 (0.32) | KIF11TSHRSMN1; SMN2 | |
| SCHEMBL19912356 | 0.89 | AR (0.35) | KIF11NR3C1PGRNR3C2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10439151-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-10-08 | — | — | US | disclosed |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10439151-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, ORC3, AOC3 | KIF11 3253/4885NR3C1 3714/4885PGR 2896/4885 |
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | KIF11 3316/4885NR3C1 3779/4885PGR 3081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.